🔎 Trials Near Me

Akèy › Kansè nan tete › Nevada › Henderson

Etid klinik pou Kansè nan tete nan Henderson, NV

6 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Henderson (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Comprehensive Cancer Centers of Nevada - Henderson, Henderson
  • Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson
  • Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson
  • ak 2 plis
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Ap rekriteFaz 3
  • Comprehensive Cancer Centers of Nevada - Henderson, Henderson
  • Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson
  • Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson
  • ak 2 plis
Laj 18 a 60 · Fanm · Mizajou Sep 2, 2026 · NCT05879926

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Ap rekriteFaz 3
  • Comprehensive Cancer Centers of Nevada, Henderson
Laj 18 a 100 · Tout sèks · Mizajou Aug 6, 2026 · NCT05232916

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Ap rekriteFaz 3
  • Comprehensive Cancer Centers of Nevada, Henderson
  • Comprehensive Cancer Centers of Nevada, Henderson
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT07062965

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Ap rekriteFaz 3
  • OptumCare Cancer Care at Seven Hills, Henderson
Laj 50 a 70 · Tout sèks · Mizajou Apr 23, 2026 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Ap rekriteEtid obsèvasyon
  • OptumCare Cancer Care at Seven Hills, Henderson
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

Etid Kansè nan tete nan lòt vil

Lòt etid nan Henderson

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.